Genertec Universal Medical Group Co Stock

Genertec Universal Medical Group Co FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Genertec Universal Medical Group Co (2666.HK) as of Aug 26, 2026 is 139.61 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -5.55 % — a change of -2,615.79% (higher).

FCF Conversion

139.61 %

YoY

-2,615.79%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Genertec Universal Medical Group Co is 2026 139.61 % . FCF Conversion Rate (FCF/EBITDA) of Genertec Universal Medical Group Co was 2025 -5.55 % . It decreases by -2,615.79% higher compared to the previous year.

The Genertec Universal Medical Group Co FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
-424.97 CNY
Jan 1, 2019
-127.94 CNY
Jan 1, 2020
-78.59 CNY
Jan 1, 2021
-91.68 CNY
Jan 1, 2022
73.94 CNY
Jan 1, 2023
194.15 CNY
Jan 1, 2024
-5.55 CNY
Jan 1, 2025
139.61 CNY
The Genertec Universal Medical Group Co FCF Conversion history
YEARFCF ConversionYoY
139.61 %-2,615.79%
-5.55 %-102.86%
194.15 %+162.57%
73.94 %-180.65%
-91.68 %+16.65%
-78.59 %-38.57%
-127.94 %-69.89%
-424.97 %-4.12%
-443.22 %+60.97%
-275.34 %-59.54%
-680.50 %-24.42%
-900.38 %—
Access this data via the Eulerpool API
Get Free API Key

Genertec Universal Medical Group Co Stock analysis

What does Genertec Universal Medical Group Co do? The company Genertec Universal Medical Group Co Ltd is a Chinese company specializing in the development, production, and sale of medical devices and products. The company was founded in 1993 and is headquartered in Beijing. Genertec Universal Medical Group Co Ltd has a broad business model, operating in various sectors focused on different medical areas. This includes medical technology, healthcare management, research and development, and medical services. In the medical technology sector, the company offers a wide range of medical devices and products. This includes ultrasound machines, EKG devices, endoscopes, ventilators, operating microscopes, X-ray machines, and many other medical devices. The devices and products of Genertec Universal Medical Group Co Ltd are known for their high quality and reliability and are in high demand by doctors and clinics worldwide. In the healthcare management sector, the company focuses on developing software and IT solutions for the medical sector. This includes specialized administrative programs for hospitals and medical practices that allow for efficient management and control of patient data. The company also places great emphasis on quality and innovation in this area. In the research and development sector, Genertec Universal Medical Group Co Ltd works closely with renowned universities and research institutions. The goal is to develop innovative medical devices and products that meet the requirements of modern medicine. The company has also achieved several important breakthroughs in this field in recent years and has established itself as an important partner in medical research. In addition to the mentioned sectors, Genertec Universal Medical Group Co Ltd also provides medical services. This includes offering specialized training and further education for doctors and medical personnel. The aim is to improve medical expertise in China and internationally and thus contribute to improving the health and well-being of patients worldwide. Overall, Genertec Universal Medical Group Co Ltd is an important player in the international medical industry. With innovative products and a clear focus on quality and reliability, the company has earned an excellent reputation in recent years and will continue to play an important role in the field of medical technology in the future. Genertec Universal Medical Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genertec Universal Medical Group Co stock

FCF Conversion Rate (FCF/EBITDA) of Genertec Universal Medical Group Co is 139.61 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Genertec Universal Medical Group Co changed from -5.55 % to 139.61 %, representing a -2,615.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Genertec Universal Medical Group Co since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Genertec Universal Medical Group Co with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Genertec Universal Medical Group Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Genertec Universal Medical Group Co